Self control of Sintrom r, for safety and quality of life of the patient anticoagulados.

In many cases, are older people with cardiovascular problems: atrial fibrillation, cardiac prosthesis metal, etc.

Take this type of medication involves a regular monitoring of the level of clotting and continually adjust the dose according to the result to avoid the (fairly high) risk of complications associated with treatment: have a hemorrhage or thrombus failure to maintain the patient in the therapeutic range or level of anticoagulation assigned according to their pathology.

This control usually done once a month in primary care or hospital centre, which will involve the patient movement, loss of working hours, etc. And for people with limited mobility these journeys pose a great difficulty.

It is shown, however, that with more regular checks (once a week and not once a month), to detect any anomaly faster, decrease the risks of complications associated with treatment. From the health centre Medical Monitor the patients anticoagulados of all Spain we offer the possibility of making this self-control from home, with a simple and reliable machine, the coagulómetro; very similarly to how do them people with diabetes.

New drugs are not safer than Sintrom ® with self-control

Scientific studies published so far put on the table the self-control method is the most reliable and secure, even above new anticoagulant drugs recently approved.

The Sintrom ® has been for many years the hegemonic anticoagulant to reduce the risk of stroke in patients with cardiac arrhythmia.

There is a new drug anticoagulant, the Dabigatran, for exclusive use, however, in atrial fibrillation; in patients who have difficulties to maintain its therapeutic range with conventional control in health centres or hospitals.

This new pill, which is presented to patients with the advantage that does not require controls, has been driven by the enthusiasm of the vast majority of cardiologists and a hype unprecedented; with the idea that arrinconará old Sintrom ®.

It is good news for patients the appearance of new drugs that can improve the already known, but it is important to give time to time to get to know exactly what role may play these new alternatives.

Patients taking Sintrom ®’s lifetime have spent years hoping to have an anticoagulant that more and better protected, have a better quality of life and not have to lose some of their precious time in waiting rooms every few days.
And the truth is that the response to this demand exists for more than 15 years: self-control, in countries such as Germany even covering the health system of health public.

Self-control with Monitor Medical patients perform its controls in your own home with a laptop coagulómetro deposit, and according to simple tables, ground treatment on a weekly basis.

With this type of control decreases by up to 60% embólicas complications and bleeding; decreases mortality and very substantially improves the quality of life.

If considered interesting to discuss this issue with medical precision, glad we ofreceríamos them the intervention of our medical team: Dr. Carlos Souto, hematologist of Sant Pau and scientific director of Medical Monitor; or the cardiac surgeon Dr. Xavier Ruyra.

Self-control, patient active and e-

Health Monitor Medical Center advocates a new concept of patient: active patient, very current concept in line with the concept of ePaciente and eHealth.

It is the patient of today’s society, assumes with self-care following a program of self-control, its treatment, and is responsible for your illness or treatment seeking information, inter alia, on the Internet.

In Monitor Medical we believe, as do all the sectors involved in the health sector, already self-care with self-control is a good alternative to improve health. Because it is shown that patients who are responsible with an active role of his illness improve quality of life (there are many studies that talk about the benefits of self-care, especially in chronic diseases). And this, ultimately impacts also on health spending.

To give all the support to this type of patient, and with the aim of offering rigorous information about their treatment, which will also contribute to increase their quality of life, we have become on the Internet reference page in self-monitoring of oral anticoagulant treatment.

Our web platform and our blog, with a section for answers to the patient, allows us to offer content on everything that is necessary to know when this type of medication is taken: adequate food, practices to be avoided or how they interact other drugs, among others.

On the other hand, our social network (Facebook and Twitter) allows our patients to discuss us his experience as a anticoagulados, that share their doubts and with information to improve their quality of life. Many patients because they take blood-thinning chronically are chronically ill.